This is a very common and important question, especially as more men are using low-dose oral minoxidil for hair loss. Based on the data we currently have, oral minoxidil at a dose of 2.5 mg daily is generally not considered a significant concern for men who are trying to conceive. Unlike certain medications used for hair loss, such as finasteride, minoxidil has not been shown to have a meaningful negative effect on male fertility, semen quality, or fetal development through paternal exposure. There is currently no strong evidence that oral minoxidil adversely affects: Sperm count Sperm motility Sperm morphology Testosterone levels Risk of birth defects through the father's use of the medication When discussing medication safety during conception, it is important to distinguish between maternal exposure and paternal exposure. The primary concern for fetal development is typically medications taken by the pregnant individual. The amount of minoxidil that could potentially be transferred through semen is considered negligible and is not believed to pose a risk to the developing fetus. That said, research specifically examining oral minoxidil and male fertility remains somewhat limited. The reassuring aspect is that after many years of clinical use, there has not been a signal suggesting significant reproductive toxicity in men taking low-dose oral minoxidil. If a man experiences side effects such as swelling, rapid heartbeat, dizziness, or significant blood pressure changes while taking oral minoxidil, those issues should be discussed with his physician, but they are separate from fertility concerns. Overall, for most healthy men, low-dose oral minoxidil 2.5 mg is generally considered compatible with attempts to conceive and is not known to negatively affect semen parameters or increase fetal risk through paternal use.